At 11 centers around the world, Abraham and other cardiovascular researchers tested the feasibility, safety and efficacy of a new transvenous phrenic nerve stimulator made by Respicardia Inc. The device resembles a pacemaker in that it delivers a regular signal to stimulate the diaphragm to breathe during sleep. In the pilot study, 47 patients were implanted with the device and evaluated for six months. The implant was placed below the collar bone ...Tuesday, 24 September 2013
Implanted Device Helps Patients With Central Sleep Apnea
At 11 centers around the world, Abraham and other cardiovascular researchers tested the feasibility, safety and efficacy of a new transvenous phrenic nerve stimulator made by Respicardia Inc. The device resembles a pacemaker in that it delivers a regular signal to stimulate the diaphragm to breathe during sleep. In the pilot study, 47 patients were implanted with the device and evaluated for six months. The implant was placed below the collar bone ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment